0000950170-23-071472.txt : 20231219 0000950170-23-071472.hdr.sgml : 20231219 20231219160529 ACCESSION NUMBER: 0000950170-23-071472 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231216 FILED AS OF DATE: 20231219 DATE AS OF CHANGE: 20231219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Imran Talat CENTRAL INDEX KEY: 0001869579 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40672 FILM NUMBER: 231497293 MAIL ADDRESS: STREET 1: C/O RANI THERAPEUTICS HOLDINGS, INC. STREET 2: 2051 RINGWOOD AVENUE CITY: SAN JOSE STATE: CA ZIP: 95131 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Rani Therapeutics Holdings, Inc. CENTRAL INDEX KEY: 0001856725 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2051 RINGWOOD AVENUE CITY: SAN JOSE STATE: CA ZIP: 95131 BUSINESS PHONE: (408) 457-3700 MAIL ADDRESS: STREET 1: 2051 RINGWOOD AVENUE CITY: SAN JOSE STATE: CA ZIP: 95131 4 1 ownership.xml 4 X0508 4 2023-12-16 0001856725 Rani Therapeutics Holdings, Inc. RANI 0001869579 Imran Talat 2051 RINGWOOD AVE SAN JOSE CA 95131 true true false false Chief Executive Officer false Stock Option (Right to Buy) 5.44 2023-12-16 4 D false 479667 D 2033-03-26 Class A Common Stock 479667 95933 D Stock Option (Right to Buy) 2.84 2023-12-16 4 A false 479667 A 2033-03-26 Class A Common Stock 479667 479667 D Stock Option (Right to Buy) 13.21 2023-12-16 4 D false 153650 D 2032-03-21 Class A Common Stock 153650 109750 D Stock Option (Right to Buy) 2.84 2023-12-16 4 A false 153650 A 2032-03-21 Class A Common Stock 153650 153650 D Stock Option (Right to Buy) 19.56 2023-12-16 4 D false 271875 D 2031-09-08 Class A Common Stock 271875 453125 D 271875 2.84 2023-12-16 4 A false 271875 A 2031-09-08 Class A Common Stock 271875 271875 D Stock Option (Right to Buy) 9.44 2023-12-16 4 D false 31252 D 2031-07-28 Class A Common Stock 31252 47699 D Stock Option (Right to Buy) 2.84 2023-12-16 4 A false 31252 A 2031-07-28 Class A Common Stock 31252 31252 D The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 27, 2023. The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date. The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options. The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 22, 2022. The shares subject to the option vest as follows: 25% of the shares subject to the option vests on June 14, 2022; and 1/48th of the shares subject to the option vest monthly over the remaining three years. The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from June 17, 2021. Talat Imran 2023-12-19